ClearPoint Neuro (CLPT) Interest Coverage Ratio Growth (3y) (2014 - 2026)
ClearPoint Neuro (CLPT) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | -35.05% |
| 10 | ClearPoint Neuro | 428.13 Mn | 392.54 Mn | 7.76 Mn | -13.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.70% |
| Dec 31, 2025 | 47.83% |
| Sep 30, 2025 | 21.91% |
| Jun 30, 2025 | -16.78% |
| Mar 31, 2025 | -10.37% |
| Dec 31, 2024 | -56.04% |
| Sep 30, 2024 | -36.42% |
| Jun 30, 2024 | -111.60% |
| Mar 31, 2024 | -127.61% |
| Dec 31, 2023 | -30.89% |
| Sep 30, 2023 | -103.78% |
| Jun 30, 2023 | -0.79% |
| Mar 31, 2023 | -4.01% |
| Dec 31, 2022 | -61.22% |
| Sep 30, 2022 | 50.33% |
| Jun 30, 2022 | 56.85% |
| Mar 31, 2022 | 46.37% |
| Dec 31, 2021 | -228.40% |
| Sep 30, 2021 | 62.97% |
| Jun 30, 2021 | 67.40% |